Free Trial

Palvella Therapeutics (PVLA) Institutional Ownership

Palvella Therapeutics logo
$28.12 +0.02 (+0.07%)
As of 01:51 PM Eastern

Institutional Ownership Changes (13F Filings) for Palvella Therapeutics (NASDAQ:PVLA)

Current
Institutional Ownership
Percentage
40.11%
Number of
Institutional Buyers
(last 12 months)
15
Total
Institutional Inflows
(last 12 months)
$48.07M
Number of
Institutional Sellers
(last 12 months)
0
Get PVLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Palvella Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

PVLA Institutional Buying and Selling by Quarter

Remove Ads

Palvella Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/19/2025 Toronto Dominion Bank13,211$159K0.0%N/A0.118%
2/18/2025 Frazier Life Sciences Management L.P.653,892$7.85M0.3%N/A5.828%
2/17/2025 Toronto Dominion Bank13,211$159K0.0%N/A0.118%
2/17/2025 Suvretta Capital Management LLC714,463$8.57M0.3%N/A6.367%
2/17/2025 DAFNA Capital Management LLC71,452$857K0.2%N/A0.637%
2/17/2025 Cresset Asset Management LLC20,911$251K0.0%N/A0.186%
2/17/2025 Citadel Advisors LLC10,408$125K0.0%N/A0.093%
2/17/2025 BVF Inc. IL696,555$8.36M0.3%N/A6.208%
2/17/2025 Adams Street Partners LLC409,666$4.92M4.4%N/A3.651%
2/14/2025 Samsara BioCapital LLC679,486$8.15M1.1%N/A6.056%
2/14/2025 Nantahala Capital Management LLC250,062$3.00M0.1%N/A2.229%
2/14/2025 Blue Owl Capital Holdings LP250,062$3.00M0.7%N/A2.229%
2/13/2025 Renaissance Technologies LLC21,371$256K0.0%N/A0.190%
2/13/2025 ADAR1 Capital Management LLC144,641$1.74M0.3%N/A1.289%
2/12/2025 Geode Capital Management LLC14,270$171K0.0%N/A0.127%
2/7/2025 BML Capital Management LLC42,130$506K0.3%N/A0.375%
(Data available from 1/1/2016 forward)

Remove Ads

PVLA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PVLA shares?

During the previous two years, 15 institutional investors and hedge funds held shares of Palvella Therapeutics. The most heavily invested institutionals were Suvretta Capital Management LLC ($8.57M), BVF Inc. IL ($8.36M), Samsara BioCapital LLC ($8.15M), Frazier Life Sciences Management L.P. ($7.85M), Adams Street Partners LLC ($4.92M), Blue Owl Capital Holdings LP ($3.00M), and Nantahala Capital Management LLC ($3.00M).Learn more on PVLA's institutional investors.

What percentage of Palvella Therapeutics stock is owned by institutional investors?

40.11% of Palvella Therapeutics stock is owned by institutional investors. Learn more on PVLA's institutional investor holdings.

Which institutional investors have been buying Palvella Therapeutics stock?

Of the 15 institutional investors that purchased Palvella Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Suvretta Capital Management LLC ($714.46K), BVF Inc. IL ($696.56K), Samsara BioCapital LLC ($679.49K), Frazier Life Sciences Management L.P. ($653.89K), Adams Street Partners LLC ($409.67K), Blue Owl Capital Holdings LP ($250.06K), and Nantahala Capital Management LLC ($250.06K).

How much institutional buying is happening at Palvella Therapeutics?

Institutional investors have bought a total of 4,005,791 shares in the last 24 months. This purchase volume represents approximately $48.07M in transactions.



This page (NASDAQ:PVLA) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners